Nuveen’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-5,833
Closed -$38K 3563
2022
Q1
$38K Sell
5,833
-434
-7% -$4.75K ﹤0.01% 3285
2021
Q4
$115K Sell
6,267
-2,266
-27% -$75.1K ﹤0.01% 3277
2021
Q3
$355K Buy
8,533
+1,900
+29% +$87.5K ﹤0.01% 3229
2021
Q2
$401K Sell
6,633
-8,434
-56% -$521K ﹤0.01% 3189
2021
Q1
$970K Hold
15,067
﹤0.01% 2892
2020
Q4
$633K Buy
+15,067
New +$546K ﹤0.01% 2970

Other funds holding GTH

Nuveen's GTH Position: Q2 2022 in Review

Nuveen sold out of Genetron Holdings Limited ADS (GTH) in Q2 2022, closing a stake of 5,833 shares — an estimated $38K sold.

Nuveen first reported a position in GTH in Q4 2020 and held it in 6 quarters. The position peaked at $970K in Q1 2021. 34 funds tracked by Wall St. Rank hold GTH as of Q2 2022.

  • Nuveen reported no remaining Genetron Holdings Limited ADS position as of Q2 2022 after selling out during the quarter.
  • Nuveen sold 5,833 Genetron Holdings Limited ADS shares in Q2 2022, an estimated $38K.
  • Nuveen first reported a position in Genetron Holdings Limited ADS in Q4 2020 and held it in 6 quarters.
  • Nuveen's Genetron Holdings Limited ADS position peaked at $970K in Q1 2021.
  • 34 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2022.

Based on Nuveen's 13F filing for Q2 2022, filed 15 Aug 2022.